Lexaria Bioscience Corp. — Director's Dealing 2009

Sep 1, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2009-08-27

Reporting Person: BUNKA CHRISTOPHER (Director, Chairman/CEO/President, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-08-27	Common Shares	P	20225	$0.065	Acquired	288725	Direct
2009-08-28	Common Shares	P	13	$0.065	Acquired	288738	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	2028998	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants	$2.4	2009-11-09	Common Shares (291700)	291700	Indirect
Warrants	$0.2	2011-07-10	Common Shares (1600000)	1600000	Indirect
Stock Options	$0.2	2011-04-26	Common Shares (100000)	100000	Direct
Stock Options	$0.2	2011-07-20	Common Shares (100000)	100000	Direct
Stock Options	$0.2	2011-07-20	Common Shares (18750)	18750	Direct
Convertible Debt	$0.05	2009-10-27	Common Shares (43333)	43333	Direct
Convertible Debt	$0.05	2010-10-27	Common Shares (43333)	43333	Direct
Convertible Debt	$0.05	2009-10-27	Common Shares (32500)	32500	Indirect
Convertible Debt	$0.05	2010-10-27	Common Shares (32500)	32500	Indirect

Footnotes

F1: Chris Bunka is the sole owner of CAB Financial Services Ltd.

F2: On July 8, 2009, the exercise price was reduced from $0.80.

F3: On July 8, 2009, the exercise price was changed from $0.12.

F4: On July 9, 2009, the exercise price was changed from $0.45.